Table 1.
Patient characteristics of 63 women with peritoneal cancer undergoing repeated pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin
| Patient characteristic | Value |
|---|---|
| Number of patients | 63 |
| Age (years; mean ± SD) | 62.0 ± 11.3 |
| Previous chemotherapy regimens (median, range) | 3 (2–8) |
| Presence of ascites | 35/63 (56.6 %) |
| Ascites volume (ml; median, range) | 150 (10–4500) |
| PCI (mean ± SD) | 17.5 ± 10.0 |
| Serum CA125 (U/ml; mean ± SD) | 1590 ± 3753 |
| Primary tumor | |
| Ovarian cancer | 58 (92.1 %) |
| Endometrial cancer | 3 (4.7 %) |
| Pseudomyxoma peritonei | 1 (1.6 %) |
| Stomach cancer | 1 (1.6 %) |
| Cell type | |
| Serous papillary adenocarcinoma | 37/63 (58.7 %) |
| Mucinous adenocarcinoma | 2/63 (3.2 %) |
| Other | 24/63 (38.1 %) |
| Number of patients sampled at PIPAC 1 and at least one follow-up PIPAC (2, 3, or 4) | 42 |
| Number of patients sampled at PIPAC 1, 2 and 3 | 28 |
SD standard deviation, PCI Peritoneal Cancer Index